4-Methylmorpholine → HCID 22313082, compound
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]([NH:10][O:11][CH3:12])=[O:9])=[CH:4][C:3]=1[NH:13][C:14]1[C:19]2=[C:20]([CH:26]([CH3:28])[CH3:27])[C:21]([C:23]([OH:25])=O)=[CH:22][N:18]2[N:17]=[CH:16][N:15]=1.Cl.[CH2:30]([NH2:32])[CH3:31].CN([P+](ON1N=NC2C=CC=CC1=2)(N(C)C)N(C)C)C.F[P-](F)(F)(F)(F)F.CN1CCOCC1>CN(C)C=O>[CH2:30]([NH:32][C:23]([C:21]1[C:20]([CH:26]([CH3:27])[CH3:28])=[C:19]2[N:18]([CH:22]=1)[N:17]=[CH:16][N:15]=[C:14]2[NH:13][C:3]1[CH:4]=[C:5]([C:8]([NH:10][O:11][CH3:12])=[O:9])[CH:6]=[CH:7][C:2]=1[F:1])=[O:25])[CH3:31]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of Example 13 (20 mg, 0.052 mmol), ethylamine hydrochloride (6 mg, 0.08 mmol), BOP reagent (34 mg, 0.08 mmol), and N-methyl morpholine (0.012 mL, 0.1 mmol) in dimethyl formamide (0.5 mL) was stirred at RT for 18 h. The mixture was purified by reverse phase HPLC. The appropriate fractions were concentrated and the residue was converted to the HCl salt to obtain the desired product as a white solid (11 mg, 50%). LC/MS; (M+H)+=415.2
Workup
- customThe mixture was purified by reverse phase HPLC
- concentrationThe appropriate fractions were concentrated
Sources & evidence
- ORD record
- ord-1347be7ff319470eb44ed43a727d5117
- Source dataset
- uspto-grants-2005_10
- Patent number
- US06951859B2
Reaction notes
Loading…